14-3-3ζ蛋白介导结外NK/T细胞淋巴瘤吉西他滨耐药
该研究探讨14-3-3ζ蛋白在结外NK/T细胞淋巴瘤鼻型(ENKTL)吉西他滨耐药中的分子机制。通过逐步增加吉西他滨浓度建立耐药YTS-gem细胞系,发现14-3-3ζ在耐药细胞中表达上调;下调14-3-3ζ可抑制细胞增殖和侵袭、恢复吉西他滨敏感性,并上调促凋亡蛋白Bax、下调抗凋亡蛋白Bcl-2等。结论提示14-3-3ζ通过抗凋亡途径诱导ENKTL对吉西他滨耐药。
要点
- 14-3-3ζ在吉西他滨耐药YTS-gem细胞中表达显著上调。
- 下调14-3-3ζ可抑制YTS和YTS-gem细胞增殖与侵袭。
- 下调14-3-3ζ可恢复YTS-gem细胞对吉西他滨的敏感性。
核心结论
- 14-3-3ζ在吉西他滨耐药的YTS细胞中表达上调,并通过抗凋亡途径诱导ENKTL对吉西他滨耐药。
研究设计与样本
- 体外研究:逐步增加吉西他滨浓度建立吉西他滨耐药YTS细胞系(YTS-gem),并以YTS细胞为对照。
- 采用siRNA下调14-3-3ζ表达,筛选稳定转染细胞克隆,比较下调前后YTS和YTS-gem细胞的功能与蛋白表达差异。
主要发现
- 与YTS细胞相比,14-3-3ζ在YTS-gem细胞中表达显著上调(P<0.05)。
- 下调14-3-3ζ后,YTS细胞和YTS-gem细胞的增殖和侵袭能力均明显受抑(P<0.05)。
- 下调14-3-3ζ后,YTS-gem细胞对吉西他滨的敏感性增加(P<0.05)。
- 下调14-3-3ζ后,YTS-gem细胞中促凋亡蛋白Bax水平显著升高,抗凋亡蛋白Bcl-2、caspase-3、cleaved caspase-3和Cyclin D1显著降低(P<0.05)。
- 下调14-3-3ζ后,YTS-gem细胞中P-gp和p53表达水平的差异无统计学意义。
临床怎么用
- 14-3-3ζ可能作为ENKTL吉西他滨耐药的潜在分子标志物和逆转耐药的干预靶点,但尚需进一步临床验证。
局限性
- 研究仅基于体外YTS细胞系,未涉及临床样本或体内模型验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To explore the molecular mechanisms of 14-3-3ζ in gemcitabine resistance in extranodal NK/T-cell lymphoma, nasal type (ENKTL) . Methods: The effects of cell proliferation and invasion were detected by cell counting kit-8 (CCK-8) assay and transwell assay. YTS cells were exposed to gradually increased concentrations of gemcitabine to establish gemcitabine-resistant YTS cells (YTS-gem) in vitro. 14-3-3ζ specific siRNA lentiviral vector was transfected into YTS and YTS-gem cells to downregulate 14-3-3ζ expression, and stable transfected cell clones were screened. The protein expression was determined by Western blot. Results: ①14-3-3ζ expression was significantly up-regulated in gemcitabine resistant YTS-gem cells, comparing with that of YTS cells (P<0.05) . ②The results of CCK-8 and transwell assay showed that downregulation of 14-3-3ζ significantly reduced the cell proliferation and invasion abilities (P<0.05) . ③Downregulation of 14-3-3ζ could restore gemcitabine sensitivity in gemcitabine resistant YTS-gem cells (P<0.05) . ④Western blotting results showed that knockdown of 14-3-3ζ significantly upregulated pro-apoptotic Bax, and downregulated anti-apoptotic Bcl-2, Caspase-3, cleaved caspase-3, Cyclin D1 in gemcitabine-resistant YTS-gem cells (P<0.05) . There was no significant difference in p53 ang P-gp expression levels. Conclusions: 14-3-3ζ was upregulated in gemcitabine resistant YTS cells. Overexpression of 14-3-3ζ promoted cell proliferation and enhanced cell migration. 14-3-3ζ contributed to gemcitabine resistance to ENKTL through anti-apoptosis. 目的: 探讨14-3-3ζ蛋白在结外NK/T细胞淋巴瘤,鼻型(ENKTL)吉西他滨耐药中的分子机制。 方法: CCK-8法检测细胞增殖,Transwell小室法检测细胞的侵袭性,逐步增加吉西他滨浓度建立吉西他滨耐药YTS细胞系(YTS-gem),MTT法检测药物敏感性,Western blot法检测14-3-3ζ蛋白在YTS-gem细胞和YTS细胞中的表达差异。采用siRNA下调14-3-3ζ表达,对比下调前后YTS-gem细胞对吉西他滨敏感性的差异。Western blot法检测耐药相关蛋白在14-3-3ζ下调前后YTS-gem细胞中的表达差异。 结果: ①与YTS细胞相比,14-3-3ζ在YTS-gem细胞中表达上调,差异有统计学意义(P<0.05);②与对照组相比,下调14-3-3ζ后YTS细胞和YTS-gem细胞的增殖和侵袭能力均明显受抑(P<0.05);③下调14-3-3ζ表达后,YTS-gem细胞对吉西他滨敏感性增加,差异有统计学意义(P<0.05);④下调14-3-3ζ表达后,YTS-gem细胞中促凋亡蛋白Bax水平显著升高,抗凋亡蛋白Bcl-2、caspase-3、cleaved caspase-3和Cyclin D1显著降低(P<0.05),而P-gp和p53表达水平的差异无统计学意义。 结论: 14-3-3ζ在YTS-gem细胞中表达上调,14-3-3ζ促进细胞增殖和侵袭,14-3-3ζ蛋白通过抗凋亡途径诱导ENKTL对吉西他滨耐药。.
引用
- Qiu YJ, Zhang MZ. [14-3-3ζ protein mediates gemcitabine resistance in NK/T-cell lymphoma]. Zhonghua Xue Ye Xue Za Zhi. 2019. PMID: 31856438. doi:10.3760/cma.j.issn.0253-2727.2019.11.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。